Novartis: 58 billion dollars of sales in 2013

Novartis has announced its full-year financial results, included sales of $58 billion, up 4% on the previous year but “narrowly missing” predictions according to The Wall Street Journal.

Joseph Jimenez, the company’s chief executive, is reportedly looking to potential joint ventures as part of a strategy to explore “unique structures”.

“Novartis delivered strong performance in 2013, growing both net sales and core operating income in constant currencies while absorbing patent expirations.

“We maintained good momentum in innovation, with 18 approvals and three FDA breakthrough therapy designations.

“Our growth products continued to expand, rejuvenating our portfolio and reinforcing our growth prospects.”

Joseph Jimenez, chief executive, Novartis.

 
 
pharmaphorum-google-plus-page

 

Related news:

Novartis earnings miss forecasts (The Wall Street Journal)

Novartis weighs joint ventures, unconventional deals for smaller businesses (Reuters).

Reference link:

Annual results (Novartis).

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.